| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.01 | 0.9 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.007 | 0.9 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | -0.0083 | 0.9 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.9 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.0087 | 0.9 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.0062 | 0.9 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |